Evaluation of Two Cell-based Assays for Diagnosing MOG-IgG Associated Disorders

RecruitingOBSERVATIONAL
Enrollment

240

Participants

Timeline

Start Date

November 18, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

December 1, 2025

Conditions
Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders
Interventions
DIAGNOSTIC_TEST

CBA method of live cells and fixed cells

"1. Study participants with high clinical suspicion of MOGAD: 2mL serum samples were collected for detection. CBA method of live cells and fixed cells was used for all samples. Sensitivity, specificity, positive predictive value and negative predictive value of the two detection methods were calculated according to the detection results and combined with the 2023 MOGAD diagnostic criteria.~2. Control group:2mL serum samples were collected for detection. CBA method of live cells and fixed cells was used for all samples."

Trial Locations (1)

200040

RECRUITING

Huashan Hospital, Shanghai

All Listed Sponsors
lead

Huashan Hospital

OTHER